Is the Metabolic Syndrome an Independent Risk Factor for Erectile Dysfunction?

2007 ◽  
Vol 177 (2) ◽  
pp. 651-654 ◽  
Author(s):  
Stefan Heidler ◽  
Christian Temml ◽  
Clemens Broessner ◽  
Karl Mock ◽  
Michael Rauchenwald ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Erectile Dysfunction ◽  
Independent Risk Factor ◽  
The Metabolic Syndrome

scholarly journals Metabolic syndrome: An independent risk factor for erectile dysfunction

2015 ◽  
Vol 19 (2) ◽  
pp. 277 ◽  
Author(s):  
Saran Sanjay ◽  
Philip Rajeev ◽  
Agroiya Puspalata ◽  
GuptaSona Bharti ◽  
Gutch Manish ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Erectile Dysfunction ◽  
Independent Risk Factor

scholarly journals The Sasang Constitution as an Independent Risk Factor for Metabolic Syndrome: Propensity Matching Analysis

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Eunsu Jang ◽  
Younghwa Baek ◽  
Kihyun Park ◽  
Siwoo Lee
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Independent Risk Factor ◽  
Continuous Variables ◽  
Chi Square ◽  
The Metabolic Syndrome ◽  
Sasang Constitution ◽  
Propensity Matching ◽  
Chi Square Test ◽  
Constitutional Medicine

The Sasang Constitutional Medicine is a traditional Korean customized medicine that classifies people into four types: Tae-eumin (TE), Soyangin (SY), Soeumin (SE), and Taeyangin. The aim of this study was to show whether the Sasang Constitution (SC) could be an independent risk factor for the metabolic syndrome (MS). Totally, 3,334 subjects from 24 Korean medicine clinics participated in this study. A one-way ANOVA for the continuous variables and a chi-square test for the prevalence of MS were conducted. A logistic regression was conducted to calculate the propensity score and the odds ratios (ORs). The prevalence for MS in TE, SY, and SE was 50.6%, 30.9%, and 17.7% (P<0.001) before matching, and 36.7%, 28.6% and 28.2% (P=0.042) after matching, respectively. The TE was associated with an increased OR for MS compared with the SE and SY in both crude (OR 4.773, 95% CI 3.889–5.859, and OR 2.292, 95% CI 1.942–2.704, resp.) and matched groups (OR 1.476, 95% CI 1.043–2.089, and OR 1.452, 95% CI 1.026–2.053, resp.). This study reveals that the SC, especially the TE type, could be considered as a risk element for MS even in people with otherwise similar physical characteristics.

Metabolic Syndrome: A Potential and Independent Risk Factor for Erectile Dysfunction in the Chinese Male Population

Urology ◽  
2012 ◽  
Vol 80 (6) ◽  
pp. 1287-1292 ◽  
Author(s):  
Kai Chen ◽  
Hua Mi ◽  
Yong Gao ◽  
Aihua Tan ◽  
Zheng Lu ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Erectile Dysfunction ◽  
Independent Risk Factor ◽  
Male Population ◽  
Chinese Male

scholarly journals Sleep and Diabetes

2010 ◽  
Vol 2010 ◽  
pp. 1-9 ◽  
Author(s):  
Swetha Bopparaju ◽  
Salim Surani
Keyword(s):  
Myocardial Infarction ◽  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Obstructive Sleep Apnea ◽  
Risk Factor ◽  
Sleep Apnea ◽  
Independent Risk Factor ◽  
The Metabolic Syndrome ◽  
Obstructive Sleep ◽  
Independent Association

Sleep apnea is clinically recognized as a heterogeneous group of disorders characterized by recurrent apnea and/or hypopnea. Its prevalence ranges from 4% to 24%. It has been implicated as an independent risk factor for several conditions such as hypertension, stroke, arrhythmia, and myocardial infarction. Recently data has been emerging which suggests an independent association of obstructive sleep apnea with several components of the metabolic syndrome, particularly insulin resistance and abnormalities in lipid metabolism. We hereby review the salient features of the association between sleep and diabetes.

1237: Erectile Dysfunction (ED) Evaluation Through the Metabolic Syndrome Window

2005 ◽  
Vol 173 (4S) ◽  
pp. 335-336 ◽  
Author(s):  
Omer Demir ◽  
Tevfik Demir ◽  
Aykut Kefi ◽  
Abdurrahman Comlekci ◽  
Sena Yesil ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Erectile Dysfunction ◽  
The Metabolic Syndrome

scholarly journals A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Lars Lind ◽  
Johan Sundström ◽  
Johan Ärnlöv ◽  
Ulf Risérus ◽  
Erik Lampa
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Longitudinal Study ◽  
Clinical Intervention ◽  
The Elderly ◽  
Adult Men ◽  
The Metabolic Syndrome ◽  
The Impact ◽  
Over 40 Years

AbstractThe impact of most, but not all, cardiovascular risk factors decline by age. We investigated how the metabolic syndrome (MetS) was related to cardiovascular disease (CVD) during 40 years follow-up in the Uppsala Longitudinal Study of Adult Men (ULSAM, 2,123 men all aged 50 at baseline with reinvestigations at age 60, 70, 77 and 82). The strength of MetS as a risk factor of incident combined end-point of three outcomes (CVD) declined with ageing, as well as for myocardial infarction, ischemic stroke and heart failure when analysed separately. For CVD, the risk ratio declined from 2.77 (95% CI 1.90–4.05) at age 50 to 1.30 (95% CI 1.05–1.60) at age 82. In conclusion, the strength of MetS as a risk factor of incident CVD declined with age. Since MetS was significantly related to incident CVD also at old age, our findings suggest that the occurrence of MetS in the elderly should not be regarded as innocent. However, since our data were derived in an observational study, any impact of MetS in the elderly needs to be verified in a randomized clinical intervention trial.

scholarly journals Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review

Antioxidants ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 270
Author(s):  
Luca Rinaldi ◽  
Pia Clara Pafundi ◽  
Raffaele Galiero ◽  
Alfredo Caturano ◽  
Maria Vittoria Morone ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Smoking Habit ◽  
Lifestyle Modifications ◽  
Alcoholic Fatty Liver ◽  
The Metabolic Syndrome ◽  
Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) are two different entities sharing common clinical and physio-pathological features, with insulin resistance (IR) as the most relevant. Large evidence leads to consider it as a risk factor for cardiovascular disease, regardless of age, sex, smoking habit, cholesterolemia, and other elements of MS. Therapeutic strategies remain still unclear, but lifestyle modifications (diet, physical exercise, and weight loss) determine an improvement in IR, MS, and both clinical and histologic liver picture. NAFLD and IR are bidirectionally correlated and, consequently, the development of pre-diabetes and diabetes is the most direct consequence at the extrahepatic level. In turn, type 2 diabetes is a well-known risk factor for multiorgan damage, including an involvement of cardiovascular system, kidney and peripheral nervous system. The increased MS incidence worldwide, above all due to changes in diet and lifestyle, is associated with an equally significant increase in NAFLD, with a subsequent rise in both morbidity and mortality due to both metabolic, hepatic and cardiovascular diseases. Therefore, the slowdown in the increase of the “bad company” constituted by MS and NAFLD, with all the consequent direct and indirect costs, represents one of the main challenges for the National Health Systems.

Sign in / Sign up

Export Citation Format

Share Document